<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04170686</url>
  </required_header>
  <id_info>
    <org_study_id>833848</org_study_id>
    <nct_id>NCT04170686</nct_id>
  </id_info>
  <brief_title>Acceptability and Efficacy of the Zemedy App for IBS</brief_title>
  <official_title>Acceptability and Efficacy of the Zemedy App for IBS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bold Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to assess if a new self-help app for IBS is an acceptable and
      effective intervention for improving the overall quality of life in patients with Irritable
      Bowel Syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 28, 2019</start_date>
  <completion_date type="Anticipated">October 28, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Irritable Bowel Syndrome Quality of LIfe</measure>
    <time_frame>8 weeks</time_frame>
    <description>A self-report measure of HRQL in people with IBS. Scores range from 0 to 100. Higher scores are a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gastrointestinal Symptom Rating Scale</measure>
    <time_frame>8 weeks</time_frame>
    <description>a self-report measure of GI symptom severity. Scores range from 0 to 78. Higher scores are a worse outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visceral Sensitivity Index</measure>
    <time_frame>8 weeks</time_frame>
    <description>self-report measure of anxiety specific to visceral sensations. Scores range from 0 to 75. Higher scores are a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GI Cognitions Questionnaire</measure>
    <time_frame>8 weeks</time_frame>
    <description>self-report measure of catastrophizing specific to GI symptoms. Scores range from 0 to 64. Higher scores are a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fear of Food Questionnaire</measure>
    <time_frame>8 weeks</time_frame>
    <description>self-report measure of fear of food. Scores range from 0 to 90. Higher scores are a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire</measure>
    <time_frame>8 weeks</time_frame>
    <description>self-report measure of depressive symptoms. Scores range from 0 to 27. Higher scores are a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression and Anxiety Stress Scales</measure>
    <time_frame>8 weeks</time_frame>
    <description>self-report measure of depressive and anxious symptoms. scores ranges from 0 to 126. Higher scores are a worse outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Immediate Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will have immediate access to the self-help app. They will take 8 weeks to work through the content at their own pace.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waitlist Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in the waitlist will receive no intervention for 8 weeks, other than a few &quot;check in&quot; emails from study personnel. At the end of 8 weeks, they will be crossed over to the active treatment group and will be given access to the app.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Zemedy App for IBS</intervention_name>
    <description>The Zemedy App for IBS is designed to be an engaging, self-help app for people with irritable bowel syndrome. It is based on empirically supported cognitive-behavioral, and GI focused hypnotherapy interventions for IBS.</description>
    <arm_group_label>Immediate Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of IBS. Own a smart phone. Speak English

        Exclusion Criteria:

          -  Under age of consent (18) Diagnosed with another GI disorder (e.g. celiac disease,
             inflammatory bowel disease)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melissa G Hunt, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melissa G Hunt, PhD</last_name>
    <phone>12158986478</phone>
    <email>mhunt@psych.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104-6018</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa G Hunt</last_name>
      <phone>215-898-6478</phone>
      <email>mhunt@psych.upenn.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 14, 2019</study_first_submitted>
  <study_first_submitted_qc>November 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2019</study_first_posted>
  <last_update_submitted>November 18, 2019</last_update_submitted>
  <last_update_submitted_qc>November 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Melissa Hunt, PhD</investigator_full_name>
    <investigator_title>Associate Director of Clinical Training</investigator_title>
  </responsible_party>
  <keyword>cognitive behavioral therapy</keyword>
  <keyword>self-help</keyword>
  <keyword>irritable bowel syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 15, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/86/NCT04170686/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

